About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Washington | 400 Studies

Clinical Trials Pancreatic CancerWashington

Pancreatic Cancer Clinical Trials in Washington

Find 400 clinical trials for pancreatic cancer near Washington. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 221-240 of 400 trials

CompletedOn-site Cytopathology EUS-FNAThis study is a multicenter prospective randomized controlled trial.NCT01386931·St Louis, Missouri TerminatedLapatinib and Capecitabine for Second Line Treatment of Pancreas CancerPatients are being asked to participate in this study who have locally advanced or metastatic pancreatic cancer (cancer of the pancreas that has spread to another part of the…NCT00881621·Washington D.C., District of Columbia

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedRX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic CancerThis will be a Phase 1b/2a multicenter 2-stage study.NCT03189914·Tucson, Arizona and 9 others

CompletedA Study of Gemcitabine and Cyberknife Radiation Therapy for Pancreatic CancerPeople with pancreatic cancer that cannot be cured by surgery are being asked to participate in this study.NCT01051284·Washington D.C., District of Columbia

TerminatedRole of Proton Pump Inhibitors on the Postoperative Course Following PancreaticoduodenectomyThe purpose of this study is to prospectively determine the effects of administering proton pump inhibitors (PPIs) following pancreaticoduodenectomy on postoperative outcomes.NCT05251233·St Louis, Missouri

CompletedErlotinib and Gemcitabine With or Without Panitumumab in Treating Patients With Metastatic Pancreatic CancerRATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00550836·Aurora, Colorado and 261 others

RecruitingMK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal AdenocarcinomaThe investigators hypothesize that MK2 inhibition may improve efficacy of mFOLFIRINOX chemotherapy for patients with pancreatic ductal adenocarcinoma (PDAC).NCT06648434·St Louis, Missouri

TerminatedVapreotide in Treating Patients Undergoing Elective Pancreatic ResectionRATIONALE: Drugs such as vapreotide may prevent complications following pancreatic resection.NCT00014651·Birmingham, Alabama and 17 others

Active not recruitingPalbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment TrialThis phase II ComboMATCH treatment trial evaluates the effectiveness of palbociclib and binimetinib in treating patients with RAS-mutated cancers.NCT05554367·Birmingham, Alabama and 264 others

RecruitingA Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Researchers are looking for a better way to treat people who have solid tumors with HER2-activating mutations.NCT06760819·Birmingham, Alabama and 53 others

Not yet recruitingSignature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic CancerThe purpose of this research study is to test a new process for diagnosing pancreatic cancer by examining changes to your DNA that can be detected from a blood test.NCT07528430·Glen Burnie, Maryland

RecruitingThe Vanguard Study: Testing a New Way to Screen for CancerThe Vanguard Study is a feasibility study to explore several aspects of evaluating multi-cancer detection (MCD) tests in a future definitive randomized controlled trial.NCT06995898·Pleasanton, California and 44 others

TerminatedStudy of Covalent Menin Inhibitor BMF-219 in Adult Patients With KRAS Driven Non-Small Cell Lung Cancer, Pancreatic Cancer, and Colorectal CancerA Phase 1/1b dose finding study to determine the OBD(s) and RP2D(s) of BMF-219, a covalent menin inhibitor small molecule, in subjects with KRAS mutated unresectable, locally…NCT05631574·Goodyear, Arizona and 22 others

TerminatedStudy With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic CancerThis study assesses the safety and efficacy of RTA 402 in combination with gemcitabine in patients with unresectable pancreatic cancer.NCT00529113·Denver, Colorado and 4 others

CompletedGemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic CancerThe Investigators in the PCRT team have developed a therapeutic regimen which attacks both the tumor compartment and the stromal compartment of pancreatic cancer and induces…NCT01488552·Scottsdale, Arizona and 4 others

Active not recruitingTesting the Addition of Pembrolizumab, an Immunotherapy Cancer Drug to Olaparib Alone as Therapy for Patients With Pancreatic Cancer That Has Spread With Inherited BRCA MutationsThis phase II trial studies whether adding pembrolizumab to olaparib (standard of care) works better than olaparib alone in treating patients with pancreatic cancer with germline…NCT04548752·Anchorage, Alaska and 532 others

CompletedEnhanced Assistance During Radiotherapy for Unmet Essential NeedsThis is a prospective single-arm study of an enhanced assistance intervention for patients with unmet essential needs undergoing \>10 fractions of radiotherapy comparing…NCT06582849·St Louis, Missouri

TerminatedPhase II Study to Evaluate Efficacy and Safety of RP101 in Combination With GemcitabineThis will be a Phase II, multicenter, randomized, double blind, placebo controlled, study of six 28-day treatment cycles for patients with locally advanced, unresectable, or…NCT00550004·Tucson, Arizona and 54 others

TerminatedStudy of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)Determining the efficacy, based upon overall survival, of ruxolitinib added to capecitabine for the treatment of advanced or metastatic pancreatic cancer.NCT02117479·Avondale, Arizona and 229 others

CompletedThe Canadian/US Integrative Oncology StudyThis study describes the survival outcomes of advanced stage breast, colorectal, ovarian and pancreatic cancer patients receiving advanced integrative oncology (AIO) treatment at…NCT02494037·Scottsdale, Arizona and 11 others

PreviousPage 12 of 20Next

Other Conditions in Washington

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia